APOA1 and Alzheimer disease: It is noteworthy that such reduction appears to be associated with a greater risk of clinical progression to MCI and AD, probably because ApoA-1 appears to play a neuroprotective role on neurons by counteracting Aβ-induced neurodegeneration [68,103,104].